circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637 - eBioMedicine
More Drugs, Better Survival in Metastatic Colon Cancer | MedPage Today
Oxaliplatin resistance in colorectal cancer enhances TRAIL sensitivity via death receptor 4 upregulation and lipid raft localization | eLife
Oxaliplatin induces chemoresistance in LoVo colon cancer cell lines.... | Download Scientific Diagram
Cetuximab Sensitivity Associated with Oxaliplatin Resistance in Colorectal Cancer | Anticancer Research
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer | NEJM
Functionalized LbL Film for Localized Delivery of STAT3 siRNA and Oxaliplatin Combination to Treat Colon Cancer | ACS Applied Materials & Interfaces
KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells | PLOS ONE
Figure 6 | Genetic variants in RPA1 associated with the response to oxaliplatin-based chemotherapy in colorectal cancer | SpringerLink
signaling pathways related to the activity of oxaliplatin and 5-fU for... | Download Scientific Diagram
The synergistic effects of oxaliplatin and piperlongumine on colorectal cancer are mediated by oxidative stress | Cell Death & Disease
miR-124 Intensified Oxaliplatin-Based Chemotherapy by Targeting CAPN2 in Colorectal Cancer: Molecular Therapy - Oncolytics
Randomised phase II trial of capecitabine plus oxaliplatin with continuous versus intermittent use of oxaliplatin as adjuvant chemotherapy for stage II/III colon cancer (CCOG-1302 study) - European Journal of Cancer
Role and mechanism of organic cation transporter 3 in oxaliplatin treatment of colon cancer in vitro and in vivo
LEF1 silencing sensitizes colorectal cancer cells to oxaliplatin, 5-FU, and irinotecan - ScienceDirect
H19 promotes the stemness and oxaliplatin resistance of colorectal... | Download Scientific Diagram
Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2: Molecular Therapy - Oncolytics
KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells | PLOS ONE
miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy
Cancers | Free Full-Text | The Optimal Duration of Adjuvant Chemotherapy in Colon Cancer | HTML
The synergistic effects of oxaliplatin and piperlongumine on colorectal cancer are mediated by oxidative stress | Cell Death & Disease
